Two-dimensional dynamic evaluation of natural killer cell-mediated lysis of adherent target cells

Alexandra Frazao1, Louise Rethacker1, Anne Caignard1

  • 1INSERM, U1160, Institut de Recherche Saint-Louis, Hôpital Saint-Louis, Paris, France.

Methods in Enzymology
|January 18, 2020
PubMed

Insights

Quantifying cell-mediated cytotoxicity is crucial for developing tumor immunotherapies. This study presents a robust method using Real-Time Cell Analysis (RTCA) to measure immune cell-mediated target cell lysis, offering a sensitive alternative to radioactive assays.

Area of Science:

  • Immunology
  • Cell Biology
  • Cancer Therapy

Background:

  • Cell-mediated cytotoxicity is a key function of cytotoxic lymphocytes, essential for tumor immunotherapy development.
  • Accurate quantification of cytotoxic function is vital for monitoring treatment efficacy.
  • Existing methods like chromium release assays have limitations, including radioactivity and incompatibility with repeated testing.

Purpose of the Study:

  • To describe a robust and sensitive method for quantifying immune cell-mediated lysis of adherent targets.
  • To present Real-Time Cell Analysis (RTCA) as an alternative to traditional cytotoxicity assays.
  • To highlight the dynamic monitoring capabilities of RTCA for evaluating therapeutic interventions.

Main Methods:

  • Utilizes Real-Time Cell Analysis (RTCA) to dynamically monitor target cell proliferation.
  • Measures the decrease in cell index values upon interaction with cytotoxic immune effectors (e.g., Natural Killer cells).
  • Quantifies target cell lysis by comparing lysis curves to controls (targets alone), expressed as percentages.

Main Results:

  • RTCA provides a sensitive and dynamic measure of immune cell-mediated lysis of adherent targets.
  • The method allows for the evaluation of drugs, cytokines, and monoclonal antibodies (mAbs) on target cell lysis.
  • Demonstrates a robust alternative to radioactive chromium release assays for cytotoxicity assessment.

Conclusions:

  • Real-Time Cell Analysis (RTCA) offers a sensitive, non-radioactive method for quantifying immune cell-mediated cytotoxicity.
  • This dynamic monitoring approach is valuable for immunomonitoring and evaluating therapeutic agents in cancer immunotherapy.
  • The described method provides a robust platform for assessing the efficacy of cytotoxic immune responses against tumors.